Angiotensin II (ANG II) is known to be a potent growth promoting factor for vascular smooth muscle cells and fibroblasts but little is known about its influence on growth in endothelial cells. We studied the effects of ANG II on endothelial growth and the role of the angiotensin receptor subtypes involved. Proliferation of rat coronary endothelial cells (CEC) and rat vascular smooth muscle cells (VSMC) was determined by [3H]thymidine incorporation, the MTT-test and by directly counting cells in a coulter counter. Angiotensin AT1- and AT2-receptors were demonstrated by binding studies and by the presence of their respective mRNA through reverse transcription polymerase chain reaction (RT-PCR). In contrast to VSMC, which in culture only express the AT1-receptor, CEC express both, AT1- and AT2-receptors simultaneously up to the third passage. Whereas ANG II stimulated growth of quiescent VSMC, an effect abolished by pretreatment with the AT1-receptor antagonist, losartan, ANG II did not induce proliferation in quiescent CEC. However, after pretreatment of quiescent endothelial cells (< passage 4) with the AT2-receptor antagonist, PD 123177, ANG II induced proliferation. This effect was reversed by additional pretreatment with losartan. ANG II significantly inhibited the proliferation of bFGF-stimulated CEC in a dose-dependent manner by maximally 50%. This effect was prevented by PD 123177 while losartan was ineffective. The AT2-receptor agonist, CGP 42112, mimicked the antiproliferative actions of ANG II, confirming the specificity of the effect. Our results show that the growth modulating actions of ANG II depend on the type of angiotensin receptor present on a given cell. In coronary endothelial cells, the antiproliferative actions of the AT2-receptor offset the growth promoting effects mediated by the AT1-receptor.
M Stoll, U M Steckelings, M Paul, S P Bottari, R Metzger, T Unger
Title and authors | Publication | Year |
---|---|---|
Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model
N Hashimoto, Y Maeshima, M Satoh, M Odawara, H Sugiyama, N Kashihara, H Matsubara, Y Yamasaki, H Makino |
American journal of physiology. Renal physiology | 2003 |
Angiotensin AT2receptors: cardiovascular hope or hype?
RE Widdop, ES Jones, RE Hannan, TA Gaspari |
British Journal of Pharmacology | 2003 |
RAS and connective tissue in the heart
Y Sun, KT Weber |
The International Journal of Biochemistry & Cell Biology | 2003 |
Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders
GH Goossens, EE Blaak, MA van Baak |
Obesity Reviews | 2003 |
Can Angiotensin-converting Enzyme Inhibitors Reverse Atherosclerosis?
JP Higgins |
Southern Medical Journal | 2003 |
Angiotensin II AT2 receptor subtype
M Volpe, B Musumeci, PD Paolis, C Savoia, A Morganti |
Journal of Hypertension | 2003 |
Retinal Angiogenesis Is Mediated by an Interaction between the Angiotensin Type 2 Receptor, VEGF, and Angiopoietin
S Sarlos, B Rizkalla, CJ Moravski, Z Cao, ME Cooper, JL Wilkinson-Berka |
The American Journal of Pathology | 2003 |
Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction
AM Salam |
Expert Opinion on Investigational Drugs | 2003 |
Effects of KD3-671, an Angiotensin II Type 1 Receptor Antagonist, on Anti-Thy-1 Nephritis in Rats
T Nagamatsu, T Oka, T Nagao, Y Suzuki |
Biological & Pharmaceutical Bulletin | 2003 |
Effects of Angiotensin II on Nitric Oxide Generation in Proliferating and Quiescent Rat Coronary Microvascular Endothelial Cells
U BAYRAKTUTAN, S ÜLKER |
Hypertension Research | 2003 |
Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats
C Pees, T Unger, P Gohlke |
The International Journal of Biochemistry & Cell Biology | 2003 |
Angiotensin II and its receptors in human endocardial endothelial cells: role in modulating intracellular calcium
D Jacques, NA Malak, S Sader, C Perreault |
Canadian Journal of Physiology and Pharmacology | 2003 |
Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells
Y Zhao, T Biermann, C Luther, T Unger, J Culman, P Gohlke |
Journal of Neurochemistry | 2003 |
Effects of angiotensin II on nitric oxide generation in growing and resting rat aortic endothelial cells
U Bayraktutan |
Journal of Hypertension | 2003 |
AT1 and AT2 receptors in human glomerular endothelial cells at different passages
B Cresci, S Giannini, L Pala, C Mavilia, C Manuelli, P Cappugi, E Magg, CM Rotella |
Microvascular Research | 2003 |
Trophic and steroidogenic effects of water deprivation on the adrenal gland of the adult female rat
D Chatelain, V Montel, A Dickes-Coopman, A Chatelain, S Deloof |
Regulatory Peptides | 2003 |
Characterization of angiotensin II–receptor subtypes in podocytes
L Wang, PJ Flannery, RF Spurney |
Journal of Laboratory and Clinical Medicine | 2003 |
The regulation of HGF and TGF-β by an angiotensin II type 1 receptor antagonist in hepatic ischemia-reperfusion injury
J Araya, T Tsuruma, K Hirata, A Yagihashi, M Meguro, M Kawakami, Y Yanai, N Watanabe |
Transplantation Proceedings | 2003 |
Effect of Angiotensin II lype 2 Receptor Blockade on Activation of Mitogen-Activated Protein Kinases after Ischemia-Reperfusion in Isolated Working Rat Hearts
D Kumar, V Menon, WR Ford, AS Clanachan, BI Jugdutt |
Journal of cardiovascular pharmacology and therapeutics | 2003 |
Expression of angiotensin type II receptor downregulates Cdk4 synthesis and inhibits cell-cycle progression
B Gingras, G Rodier, E Giasson, P Coulombe, C Chassagne, S Meloche |
Oncogene | 2003 |
Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice
X Yan, RL Price, M Nakayama, K Ito, AJ Schuldt, WJ Manning, A Sanbe, TK Borg, J Robbins, BH Lorell |
American journal of physiology. Heart and circulatory physiology | 2003 |
Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage
V Grishko, V Pastukh, V Solodushko, M Gillespie, J Azuma, S Schaffer |
American journal of physiology. Heart and circulatory physiology | 2003 |
A role for angiotensin II AT 1 receptors in ureteric bud cell branching
IV Iosipiv, M Schroeder |
American journal of physiology. Renal physiology | 2003 |
Hypoxia and high glucose upregulate AT 1 receptor expression and potentiate ANG II-induced proliferation in VSM cells
CP Sodhi, YS Kanwar, A Sahai |
American journal of physiology. Heart and circulatory physiology | 2003 |
Angiotensin II mediates LDL-induced superoxide generation in mesangial cells
SY Park, CY Song, BC Kim, HK Hong, HS Lee |
American journal of physiology. Renal physiology | 2003 |
An AT1-Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor Protect Against Hypoxia-Induced Apoptosis in Human Aortic Endothelial Cells Through Upregulation of Endothelial Cell Nitric Oxide Synthase Activity:
N Matsumoto, H Manabe, J Ochiai, N Fujita, T Takagi, M Uemura, Y Naito, N Yoshida, S Oka, T Yoshikawa |
Shock | 2003 |
Differential regulation of in vivo angiogenesis by angiotensin II receptors
T Walther, A Menrad, HD Orzechowski, G Siemeister, M Paul, M Schirner |
The FASEB Journal | 2003 |
Cardiac Angiotensin II Type 2 Receptor Activates the Kinin/NO System and Inhibits Fibrosis
S Kurisu, R Ozono, T Oshima, M Kambe, T Ishida, H Sugino, H Matsuura, K Chayama, Y Teranishi, O Iba, K Amano, H Matsubara |
Hypertension | 2003 |
Cardiac Remodeling and Failure
PK Singal, IM Dixon, LA Kirshenbaum, NS Dhalla |
2003 | |
Increased Renal Vascular Endothelial Growth Factor and Angiopoietins by Angiotensin II Infusion Is Mediated by Both AT 1 and AT 2 Receptors
B Rizkalla, JM Forbes, ME Cooper, Z Cao |
Journal of the American Society of Nephrology : JASN | 2003 |